We are committed to serving the best interests of our shareholders. You will find key shareholder information and financial reports available to help put CombiMatrix Corporation's financial performance into perspective.
Jun 24, 2016
CombiMatrix Study Published in Genetics in Medicine Establishes the Superior Diagnostic Value of Microarray Analysis over Karyotyping for Recurrent Pregnancy Loss Testing
Jun 1, 2016
CombiMatrix Launches Next Generation Sequencing for Pre-Implementation Genetic Screening
View all releases »